ATE375990T1 - Piperidin-indol derivate mit 5-ht6 affinität - Google Patents
Piperidin-indol derivate mit 5-ht6 affinitätInfo
- Publication number
- ATE375990T1 ATE375990T1 AT99915418T AT99915418T ATE375990T1 AT E375990 T1 ATE375990 T1 AT E375990T1 AT 99915418 T AT99915418 T AT 99915418T AT 99915418 T AT99915418 T AT 99915418T AT E375990 T1 ATE375990 T1 AT E375990T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- 4alkyl
- 4alkoxy
- halo
- affinity
- Prior art date
Links
- XVTILWLVPDMCSO-UHFFFAOYSA-N 1h-indole;piperidine Chemical class C1CCNCC1.C1=CC=C2NC=CC2=C1 XVTILWLVPDMCSO-UHFFFAOYSA-N 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 7
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 5
- 125000001475 halogen functional group Chemical group 0.000 abstract 5
- -1 C3-7cycloalkyloxy Chemical group 0.000 abstract 3
- 108091005435 5-HT6 receptors Proteins 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000002475 indoles Chemical class 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CA1999/000342 WO2000063203A1 (en) | 1999-04-21 | 1999-04-21 | Piperidine-indole compounds having 5-ht6 affinity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE375990T1 true ATE375990T1 (de) | 2007-11-15 |
Family
ID=4173364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99915418T ATE375990T1 (de) | 1999-04-21 | 1999-04-21 | Piperidin-indol derivate mit 5-ht6 affinität |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1173432B9 (de) |
| JP (1) | JP4597386B2 (de) |
| AT (1) | ATE375990T1 (de) |
| AU (1) | AU778682B2 (de) |
| CA (1) | CA2370147C (de) |
| DE (1) | DE69937372T2 (de) |
| ES (1) | ES2291024T4 (de) |
| MX (1) | MXPA01010655A (de) |
| WO (1) | WO2000063203A1 (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1803720A1 (de) * | 2000-12-22 | 2007-07-04 | Wyeth a Corporation of the State of Delaware | Hetorocyclindazole und -Azaindazole Verbindungen als 5-Hydroxytryptamine-6 Liganden |
| MXPA03005432A (es) * | 2000-12-22 | 2003-09-10 | Wyeth Corp | Compuestos de heterociclilindazol y -azaindazol como ligandos de 5-hidroxitriptamina-6. |
| ATE340795T1 (de) | 2001-01-30 | 2006-10-15 | Lilly Co Eli | Benzolsulfonsäureester-indol-5-yl als 5-ht6 rezeptor-antagonisten |
| EP1401813B1 (de) * | 2001-06-07 | 2007-02-07 | F. Hoffman-la Roche AG | Neue indolderivate mit affinität zum 5-ht6-rezeptor |
| ITRM20010356A1 (it) * | 2001-06-21 | 2002-12-23 | Sigma Tau Ind Farmaceuti | "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina. |
| TW200301251A (en) * | 2001-12-20 | 2003-07-01 | Wyeth Corp | Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| WO2003065046A2 (en) * | 2002-02-01 | 2003-08-07 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor |
| BRPI0308696B8 (pt) * | 2002-03-27 | 2021-05-25 | Axovant Sciences Gmbh | composto derivado de quinolina, seu processo de preparação, sua composição farmacêutica e seus usos |
| BRPI0315959C1 (pt) * | 2002-11-28 | 2021-05-25 | Suven Life Sciences Ltd | composto, composição farmacêutica, uso do composto, método para o tratamento, método para reduzir a morbidez e a mortalidade associadas com o excesso de peso e processo para a preparação do composto |
| EP1592690A1 (de) | 2003-02-14 | 2005-11-09 | Wyeth | Heterocyclyl-3-sulfonylazaindol- oder -azaindazolderivate als 5-hydroxytryptamin-6-liganden |
| WO2005005439A1 (en) * | 2003-07-09 | 2005-01-20 | Suven Life Sciences Limited | Benzothiazino indoles |
| PT1558582E (pt) | 2003-07-22 | 2006-05-31 | Arena Pharm Inc | Derivados de diaril- e aril-heteroaril-ureia como moduladores do receptor de serotonina 5-ht2a uteis para a profilaxia e tratamento de desordens relacionadas com o mesmo |
| GB0321473D0 (en) * | 2003-09-12 | 2003-10-15 | Glaxo Group Ltd | Novel compounds |
| CA2637531A1 (en) * | 2006-02-17 | 2007-08-30 | Memory Pharmaceuticals Corporation | Compounds having 5-ht6 receptor affinity |
| AU2007343063B2 (en) | 2007-01-08 | 2011-02-17 | Suven Life Sciences Limited | 5-(Heterocyclyl)alkyl-N-(arylsulfonyl)indole compounds and their use as 5-HT6 ligands |
| US8507469B2 (en) | 2007-03-23 | 2013-08-13 | Abbott Gmbh & Co. Kg | Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
| BRPI0809873A2 (pt) | 2007-05-03 | 2018-11-13 | Suven Life Sciences Ltd | "composto, processo para a preparação do composto, método para o tratamento de uma desordem do sistema nervoso central, composição farmacêutica, uso do composto, método para testar antagonistas e antagonistas com seletividade para o receptor 5-th6 e método de tratamento" |
| CN101835748B (zh) | 2007-10-26 | 2012-11-14 | 苏文生命科学有限公司 | 氨基芳基磺胺化合物及其作为5-ht6配体的用途 |
| EP2508177A1 (de) | 2007-12-12 | 2012-10-10 | Glaxo Group Limited | Kombinationen mit 3-phenylsulfonyl-8-piperazinyl-1yl-chinolin |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| WO2010032257A1 (en) | 2008-09-17 | 2010-03-25 | Suven Life Sciences Limited | Aryl indolyl sulfonamide compounds and their use as 5-ht6 ligands |
| EP2346847B1 (de) | 2008-09-17 | 2013-05-15 | Suven Life Sciences Limited | Arylsulfonamidaminverbindungen und deren verwendung als 5-ht6-liganden |
| WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
| CA2786072C (en) | 2010-01-05 | 2014-10-28 | Suven Life Sciences Limited | Sulfone compounds as 5-ht6 receptor ligands |
| WO2015090233A1 (en) | 2013-12-20 | 2015-06-25 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic compounds and their application in pharmaceuticals |
| EP3166924B1 (de) | 2014-07-08 | 2019-02-20 | Sunshine Lake Pharma Co., Ltd. | Aromatische heterocyclische derivate und pharmazeutische anwendungen davon |
| WO2016201373A1 (en) | 2015-06-12 | 2016-12-15 | Axovant Sciences Ltd. | Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of rem sleep behavior disorder |
| WO2017011767A2 (en) | 2015-07-15 | 2017-01-19 | Axovant Sciences Ltd. | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease |
| CN116917305A (zh) * | 2020-12-07 | 2023-10-20 | 明德赛特制药公司 | 用于治疗cns病症的作为血清素能剂的3-环状胺-吲哚衍生物 |
| CA3229361A1 (en) * | 2021-08-20 | 2023-02-23 | Abdelmalik Slassi | 3-cycloamino-indole compounds as serotonergic agents useful for the treatment of disorders related thereto |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
| DK158590D0 (da) * | 1990-07-02 | 1990-07-02 | Lundbeck & Co As H | Indolderivater |
| TW263508B (de) * | 1991-02-12 | 1995-11-21 | Pfizer | |
| US5846982A (en) * | 1996-06-14 | 1998-12-08 | Eli Lilly And Company | Inhibition of serotonin reuptake |
-
1999
- 1999-04-21 AT AT99915418T patent/ATE375990T1/de not_active IP Right Cessation
- 1999-04-21 WO PCT/CA1999/000342 patent/WO2000063203A1/en not_active Ceased
- 1999-04-21 DE DE69937372T patent/DE69937372T2/de not_active Expired - Lifetime
- 1999-04-21 JP JP2000612293A patent/JP4597386B2/ja not_active Expired - Fee Related
- 1999-04-21 MX MXPA01010655A patent/MXPA01010655A/es active IP Right Grant
- 1999-04-21 AU AU34035/99A patent/AU778682B2/en not_active Ceased
- 1999-04-21 CA CA002370147A patent/CA2370147C/en not_active Expired - Fee Related
- 1999-04-21 ES ES99915418T patent/ES2291024T4/es not_active Expired - Lifetime
- 1999-04-21 EP EP99915418A patent/EP1173432B9/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2370147A1 (en) | 2000-10-26 |
| AU778682B2 (en) | 2004-12-16 |
| AU3403599A (en) | 2000-11-02 |
| EP1173432A1 (de) | 2002-01-23 |
| DE69937372D1 (de) | 2007-11-29 |
| DE69937372T2 (de) | 2008-06-26 |
| ES2291024T3 (es) | 2008-02-16 |
| EP1173432B9 (de) | 2008-10-15 |
| CA2370147C (en) | 2009-07-28 |
| ES2291024T4 (es) | 2009-03-01 |
| EP1173432B1 (de) | 2007-10-17 |
| JP2002542241A (ja) | 2002-12-10 |
| MXPA01010655A (es) | 2002-11-04 |
| JP4597386B2 (ja) | 2010-12-15 |
| WO2000063203A1 (en) | 2000-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE375990T1 (de) | Piperidin-indol derivate mit 5-ht6 affinität | |
| CA2287551A1 (en) | 3-(2-pyrrolidinylmethyl)-indole compounds having 5-ht6 affinity | |
| GB9801690D0 (en) | Therapeutic agents | |
| DK0841929T3 (da) | Quinoloner og deres terapeutiske anvendelse | |
| WO2002046129A3 (en) | Inhibitors of histone deacetylase | |
| DK1104760T3 (da) | Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler | |
| BR0109703A (pt) | Derivados de piperazina | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| DK0889877T3 (da) | Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer | |
| CA2335285A1 (en) | Bicyclic piperidine and piperazine compounds having 5-ht6 receptor affinity | |
| IL114315A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same for inhibiting phosphodiesterase IV | |
| NO950297D0 (no) | Prolinamidderivater | |
| ATE350036T1 (de) | Tetrahydroquinolin-derivate | |
| NO963731L (no) | Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister | |
| WO2000008048A3 (en) | Inhibitor of histone deacetylase | |
| PL338352A1 (en) | Derivatives of 1-(n-phenylaminoalkyl)-piperazine substituted at position 2 of its phenyl ring | |
| BR9509671C1 (pt) | Derivados de dibenzimidazol | |
| PT1104759E (pt) | Compostos heteroaril-fenil-pirazole como agentes anti-inflamatorios e analgesicos | |
| WO2000005214A3 (en) | Isoquinolines as urokinase inhibitors | |
| PT1204658E (pt) | Agonistas benzofurilpiperazina de serotonina | |
| AU2001261707A1 (en) | Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives | |
| EP0816338A4 (de) | 3-(bis-substituierte-phenylmethylen)oxindol-derivate | |
| DK0683170T3 (da) | Glucopyranosidbenzothiophener | |
| DE69909097D1 (de) | 5-bicycloindolverbindungen | |
| JPS5515443A (en) | Antibacterial agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |